All Stories

  1. Mapping antimicrobial resistance and healthcare-associated infections indicators for actionable benchmarking: a cross-network overview in a data-driven era

    Article • Antimicrobial Resistance and Infection Control, December 2025, Springer Science + Business Media

    Professor JEROME ROBERT

  2. Evaluation of imipenem-relebactam, meropenem-vaborbactam, aztreonam-avibactam and cefepime-zidebactam activities on a wide collection of French clinical Enterobacterales isolates

    Article • Diagnostic Microbiology and Infectious Disease, November 2025, Elsevier

    Professor JEROME ROBERT

  3. Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort study

    Article • The Lancet Regional Health - Europe, September 2025, Elsevier

    Professor JEROME ROBERT

  4. Standardised protocol for the detection and quantification of nontuberculous mycobacteria (NTM) in tap water and its application in investigating the source of NTM clinical infections

    Article • International Journal of Hygiene and Environmental Health, July 2025, Elsevier

    Professor JEROME ROBERT

  5. Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment

    Article • Emerging Infectious Diseases, March 2025, Centers for Disease Control and Prevention (CDC)

    Professor JEROME ROBERT

  6. Incidence, severity and treatment outcome of tuberculosis in the era of the COVID-19 pandemic, France, 2018–2023

    Article • Journal of Epidemiology and Population Health, February 2025, Elsevier

    Professor JEROME ROBERT

  7. Mycobacterium chelonae cutaneous infections unrelated to invasive procedures: A multicentre retrospective case series

    Article • Journal of the European Academy of Dermatology and Venereology, December 2024, Wiley

    Professor JEROME ROBERT

  8. Re: ‘Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe’ by Lange et al.

    Article • Clinical Microbiology and Infection, September 2024, Elsevier

    Professor JEROME ROBERT

  9. Lessons learned from treating drug-resistant TB and how to apply these to drug-susceptible TB

    Article • The International Journal of Tuberculosis and Lung Disease, July 2024, International Union Against Tuberculosis and Lung Disease

    Professor JEROME ROBERT

  10. A predictive score for the result of carbapenem-resistant Enterobacterales and vancomycin-resistant enterococci screening

    Article • Journal of Hospital Infection, June 2024, Elsevier

    Professor JEROME ROBERT

  11. Mutation Rate of AmpC β-Lactamase–Producing Enterobacterales and Treatment in Clinical Practice: A Word of Caution

    Article • Clinical Infectious Diseases, March 2024, Oxford University Press (OUP)

    Professor JEROME ROBERT

  12. Novel scores relevant to antimicrobial resistance and hospital-acquired infections developed with data from a multi-hospital consortium in the Parisian region of France

    Article • Journal of Hospital Infection, January 2024, Elsevier

    Professor JEROME ROBERT

  13. Diagnosis and treatment of bacterial peritonitis in patients with gastrointestinal cancer: an observational multicenter study

    Article • Therapeutic Advances in Medical Oncology, January 2024, SAGE Publications

    Professor JEROME ROBERT

  14. L’infection à Mycobacterium ulcerans ou ulcère de Buruli

    Article • Bulletin de l Académie Nationale de Médecine, October 2023, Elsevier

    Professor JEROME ROBERT

  15. Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-centre retrospective propensity-weighted study

    Article • International Journal of Antimicrobial Agents, July 2023, Elsevier

    Professor JEROME ROBERT

  16. Corrigendum to “Pharmacokinetics/pharmacodynamics of ceftobiprole in patients on extracorporeal membrane oxygenation” [International Journal of Antimicrobial Agents Volume 61 (2023)106765]

    Article • International Journal of Antimicrobial Agents, June 2023, Elsevier

    Professor JEROME ROBERT

  17. Pharmacokinetics/pharmacodynamics of ceftobiprole in patients on extracorporeal membrane oxygenation

    Article • International Journal of Antimicrobial Agents, April 2023, Elsevier

    Professor JEROME ROBERT

  18. Active tuberculosis screening among the displaced population fleeing Ukraine, France, February to October 2022

    Article • Eurosurveillance, March 2023, European Centre for Disease Control and Prevention (ECDC)

    Professor JEROME ROBERT

  19. Rapid selection of a cefiderocol-resistantEscherichia coliproducing NDM-5 associated with a single amino acid substitution in the CirA siderophore receptor

    Article • Journal of Antimicrobial Chemotherapy, March 2023, Oxford University Press (OUP)

    Professor JEROME ROBERT

  20. Impact de la première année de la pandémie de COVID-19 sur l’épidémiologie des infections invasives (bactériémies) dans les hôpitaux de l’Assistance Publique–Hôpitaux de Paris

    Article • Bulletin de l Académie Nationale de Médecine, February 2023, Elsevier

    Professor JEROME ROBERT

  21. Antibiotic Stewardship in Treatment of Osteoarticular Infections Based on Local Epidemiology and Bacterial Growth Times

    Article • Microbiology Spectrum, December 2022, ASM Journals

    Professor JEROME ROBERT

  22. Investigation of healthcare-associated COVID-19 in a large French hospital group by whole-genome sequencing

    Article • Microbiological Research, October 2022, Elsevier

    Professor JEROME ROBERT

  23. Decrease of hospital- and community-acquired bloodstream infections due to Streptococcus pneumoniae and Streptococcus pyogenes during the first year of the COVID-19 pandemic: A time-series analysis in Paris region

    Article • American Journal of Infection Control, September 2022, Elsevier

    Professor JEROME ROBERT

  24. Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019

    Article • Emerging Infectious Diseases, September 2022, Centers for Disease Control and Prevention (CDC)

    Professor JEROME ROBERT

  25. Early-onset neonatal sepsis in the Paris area: a population-based surveillance study from 2019 to 2021

    Article • Archives of Disease in Childhood Fetal & Neonatal, July 2022, BMJ

    Professor JEROME ROBERT

  26. Molecular detection of isoniazid monoresistance improves tuberculosis treatment: A retrospective cohort in France

    Article • Journal of Infection, July 2022, Elsevier

    Professor JEROME ROBERT

  27. Decrease of carbapenemase‐producing Enterobacteriaceae incidence during the first year of the COVID‐19 pandemic

    Article • Journal of Infection, July 2022, Elsevier

    Professor JEROME ROBERT

  28. Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment

    Article • Clinical Infectious Diseases, June 2022, Oxford University Press (OUP)

    Professor JEROME ROBERT

  29. atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure

    Article • Emerging Infectious Diseases, May 2022, Centers for Disease Control and Prevention (CDC)

    Professor JEROME ROBERT

  30. Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012‒2020

    Article • Emerging Infectious Diseases, March 2022, Centers for Disease Control and Prevention (CDC)

    Professor JEROME ROBERT

  31. Clinical, epidemiological and therapeutic characteristics of Mycoplasma genitalium infection in a French STI center

    Article • Infectious Diseases Now, February 2022, Elsevier

    Professor JEROME ROBERT

  32. Surging bloodstream infections and antimicrobial resistance during the first wave of COVID–19: a study in a large multihospital institution in the Paris region

    Article • International Journal of Infectious Diseases, January 2022, Elsevier

    Professor Martin M Rottman, Professor JEROME ROBERT

  33. Corynebacterium striatum thrombophlebitis: a nosocomial multidrug-resistant disease?

    Article • Access Microbiology, December 2021, Society for General Microbiology

    Professor JEROME ROBERT

  34. A Comprehensive Evaluation of GeneLEAD VIII DNA Platform Combined to Deeplex Myc-TB® Assay to Detect in 8 Days Drug Resistance to 13 Antituberculous Drugs and Transmission of Mycobacterium tuberculosis Complex Directly From Clinical Samples

    Article • Frontiers in Cellular and Infection Microbiology, October 2021, Frontiers

    Professor JEROME ROBERT

  35. Clostridioides difficile Infection Rates after Ceftolozane–Tazobactam and Ceftazidime–Avibactam Treatment Compared to Carbapenem Treatment: A Retrospective Single-Center Study

    Article • Hygiene, October 2021, MDPI AG

    Professor JEROME ROBERT

  36. Ciprofloxacin population pharmacokinetics during long-term treatment of osteoarticular infections

    Article • Journal of Antimicrobial Chemotherapy, August 2021, Oxford University Press (OUP)

    Professor JEROME ROBERT

  37. Impact of stewardship strategy on antibiotic use in Clostridoides difficile infection

    Article • Infectious Diseases Now, August 2021, Elsevier

    Professor JEROME ROBERT

  38. Controlling healthcare-associated transmission of SARS-CoV-2 variant of concern 202012/01 in a large hospital network

    Article • Journal of Hospital Infection, August 2021, Elsevier

    Professor JEROME ROBERT

  39. Rapid Molecular Diagnosis of Tuberculosis and Its Resistance to Rifampicin and Isoniazid with Automated MDR/MTB ELITe MGB® Assay

    Article • Antibiotics, June 2021, MDPI AG

    Professor JEROME ROBERT

  40. Isoniazid-monoresistant tuberculosis in France: Risk factors, treatment outcomes and adverse events

    Article • International Journal of Infectious Diseases, June 2021, Elsevier

    Professor JEROME ROBERT

  41. Sampling strategy for bacteriological diagnosis of intrathoracic tuberculosis

    Article • Respiratory Medicine and Research, May 2021, Elsevier

    Professor JEROME ROBERT

  42. Impact of the revised definition of extensively drug-resistant tuberculosis

    Article • European Respiratory Journal, April 2021, European Respiratory Society (ERS)

    nicolas veziris, Professor JEROME ROBERT

  43. Mycobacterium chimaera Genomics With Regard to Epidemiological and Clinical Investigations Conducted for an Open Chest Postsurgical Mycobacterium chimaera Infection Outbreak

    Article • Open Forum Infectious Diseases, April 2021, Oxford University Press (OUP)

    Professor JEROME ROBERT

  44. Efficacy of aztreonam with ß-lactamase inhibitors against metallo-carbapenemase-producing Enterobacteria

    Article • Infectious Diseases Now, February 2021, Elsevier

    Professor JEROME ROBERT

  45. Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort Study

    Article • Microorganisms, January 2021, MDPI AG

    Professor JEROME ROBERT

  46. Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study

    Article • Annals of Intensive Care, November 2020, Springer Science + Business Media

    Professor JEROME ROBERT

  47. Do Contact Precautions Reduce the Incidence of Intensive Care Unit–Acquired Pseudomonas aeruginosa Infections? The DPCPYO (Detection and Contact Precautions for Patients With P. aeruginosa) Cluster-Randomized Crossover Trial

    Article • Clinical Infectious Diseases, November 2020, Oxford University Press (OUP)

    Professor JEROME ROBERT

  48. Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety

    Article • European Journal of Internal Medicine, October 2020, Elsevier

    Professor JEROME ROBERT

  49. Telacebec (Q203)-containing intermittent oral regimens sterilized mice infected with Mycobacterium ulcerans after only 16 doses

    Article • PLoS Neglected Tropical Diseases, August 2020, PLOS

    Professor JEROME ROBERT

  50. Combining bacteriophages and dalbavancin for salvage therapy of complex Staphylococcus aureus extradural empyema

    Article • Médecine et Maladies Infectieuses, August 2020, Elsevier

    Professor JEROME ROBERT

  51. Usefulness of point-of-care multiplex PCR to rapidly identify pathogens responsible for ventilator-associated pneumonia and their resistance to antibiotics: an observational study

    Article • Critical Care, June 2020, Springer Science + Business Media

    Professor JEROME ROBERT

  52. Validation of the Bacterial Meningitis Score in adults consulting at an emergency department: a retrospective multicentric study

    Article • European Journal of Emergency Medicine, June 2020, Wolters Kluwer Health

    Professor JEROME ROBERT

  53. Bedaquiline and delamanid for drug-resistant tuberculosis: a clinician’s perspective

    Article • Future Microbiology, June 2020, Future Medicine

    Professor JEROME ROBERT

  54. Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial

    Article • The Lancet, April 2020, Elsevier

    Professor JEROME ROBERT

  55. Rational Choice of Antibiotics and Media for Mycobacterium avium Complex Drug Susceptibility Testing

    Article • Frontiers in Microbiology, February 2020, Frontiers

    Professor JEROME ROBERT

  56. Awareness among French healthcare workers of the transmission of multidrug resistant organisms: a large cross-sectional survey

    Article • Antimicrobial Resistance and Infection Control, November 2019, Springer Science + Business Media

    Professor JEROME ROBERT

  57. Q203 containing fully intermittent oral regimens exhibited high sterilizing activity against Mycobacterium ulcerans in mice

    Article • October 2019, Cold Spring Harbor Laboratory Press

    Professor JEROME ROBERT

  58. Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium

    Article • The International Journal of Tuberculosis and Lung Disease, October 2019, International Union Against Tuberculosis and Lung Disease

    Professor JEROME ROBERT

  59. A nationwide survey on involvement of clinical microbiologists in antibiotic stewardship programmes in large French hospitals

    Article • European Journal of Clinical Microbiology & Infectious Diseases, August 2019, Springer Science + Business Media

    Professor JEROME ROBERT

  60. Erwinia billingiaeas Unusual Cause of Septic Arthritis, France, 2017

    Article • Emerging Infectious Diseases, August 2019, Centers for Disease Control and Prevention (CDC)

    Professor JEROME ROBERT

  61. Trends and prediction of antimicrobial susceptibility in urinary bacteria isolated in European emergency departments: the EuroUTI 2010-2016 Study

    Article • Journal of Antimicrobial Chemotherapy, June 2019, Oxford University Press (OUP)

    Professor JEROME ROBERT

  62. Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis

    Article • Emerging Infectious Diseases, May 2019, Centers for Disease Control and Prevention (CDC)

    Professor JEROME ROBERT

  63. Molecular epidemiology of Pseudomonas aeruginosa isolated from infected ICU patients: a French multicenter 2012–2013 study

    Article • European Journal of Clinical Microbiology & Infectious Diseases, March 2019, Springer Science + Business Media

    Professor JEROME ROBERT

  64. Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study

    Article • European Journal of Clinical Microbiology & Infectious Diseases, November 2018, Springer Science + Business Media

    Professor JEROME ROBERT

  65. Introduction – épidémiologie de la tuberculose et de l’infection tuberculeuse latente

    Article • Revue des Maladies Respiratoires, October 2018, Elsevier

    Professor JEROME ROBERT

  66. Recommandations pratiques pour l’utilisation et l’interprétation des tests de détection de l’interféron gamma dans le diagnostic de l’infection tuberculeuse latente et de la tuberculose maladie

    Article • Revue des Maladies Respiratoires, October 2018, Elsevier

    Professor JEROME ROBERT

  67. Poor Performance of Rapid Molecular Tests to Define Eligibility for the Shortcourse Multidrug-resistant Tuberculosis Regimen

    Article • Clinical Infectious Diseases, September 2018, Oxford University Press (OUP)

    Professor JEROME ROBERT

  68. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

    Article • The Lancet, September 2018, Elsevier

    Professor JEROME ROBERT

  69. Trimethoprim susceptibility in E. coli community-acquired urinary tract infections in France

    Article • Médecine et Maladies Infectieuses, September 2018, Elsevier

    Professor JEROME ROBERT

  70. Management and outcome of bloodstream infections: a prospective survey in 121 French hospitals (SPA-BACT survey)

    Article • Infection and Drug Resistance, August 2018, Dove Medical Press

    Professor JEROME ROBERT

  71. Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016

    Article • BMC Infectious Diseases, July 2018, Springer Science + Business Media

    Professor JEROME ROBERT

  72. Bacillus cereus, a serious cause of nosocomial infections: Epidemiologic and genetic survey

    Article • PLOS One, May 2018, PLOS

    Professor JEROME ROBERT

  73. A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study

    Article • The Lancet Infectious Diseases, April 2018, Elsevier

    Professor JEROME ROBERT, Dr Peter Michael Keller

  74. Comparison of methods available for identification of Mycobacterium chimaera

    Article • Clinical Microbiology and Infection, April 2018, Elsevier

    Professor JEROME ROBERT

  75. Surveillance for control of antimicrobial resistance

    Article • The Lancet Infectious Diseases, March 2018, Elsevier

    Professor JEROME ROBERT

  76. Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant Enterococcus faecium outbreaks: a 6-year prospective study in a French multihospital institution, January 2010 to December 2015

    Article • Eurosurveillance, February 2018, European Centre for Disease Control and Prevention (ECDC)

    Professor JEROME ROBERT

  77. Safety and efficacy of exposure to bedaquiline−delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia

    Article • European Respiratory Journal, February 2018, European Respiratory Society (ERS)

    Lorenzo Guglielmetti, Professor JEROME ROBERT

  78. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study

    Article • The International Journal of Tuberculosis and Lung Disease, January 2018, International Union Against Tuberculosis and Lung Disease

    Professor JEROME ROBERT

  79. Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria

    Article • American Review of Respiratory Disease, December 2017, American Thoracic Society

    Dr Frank van Leth, Professor JEROME ROBERT, Dr Valeriu Crudu

  80. Xe Congrès international de la Société de pathologie exotique, 8-9 novembre 2017, Haïphong (Vietnam) – Accès à la chirurgie en zones tropicales

    Article • Bulletin de la Société de pathologie exotique, December 2017, Lavoisier

    Professor JEROME ROBERT

  81. Molecular detection methods of resistance to antituberculosis drugs in Mycobacterium tuberculosis

    Article • Médecine et Maladies Infectieuses, September 2017, Elsevier

    Professor JEROME ROBERT

  82. Bacterial biofilm under flow: First a physical struggle to stay, then a matter of breathing

    Article • PLOS One, April 2017, PLOS

    Professor JEROME ROBERT

  83. Erratum to ‘Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae’ [International Journal of Antimicrobial Agents 49/1 67–73]

    Article • International Journal of Antimicrobial Agents, April 2017, Elsevier

    Professor JEROME ROBERT

  84. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria

    Article • Journal of Antimicrobial Chemotherapy, February 2017, Oxford University Press (OUP)

    Professor JEROME ROBERT

  85. Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosi s in France

    Article • Antimicrobial Agents and Chemotherapy, February 2017, ASM Journals

    Professor JEROME ROBERT

  86. Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries

    Article • The International Journal of Tuberculosis and Lung Disease, February 2017, International Union Against Tuberculosis and Lung Disease

    Professor JEROME ROBERT

  87. Multidrug and extensively drug-resistant tuberculosis

    Article • Médecine et Maladies Infectieuses, February 2017, Elsevier

    Professor JEROME ROBERT

  88. Development of an algorithm for phenotypic screening of carbapenemase-producing Enterobacteriaceae in the routine laboratory

    Article • BMC Infectious Diseases, January 2017, Springer Science + Business Media

    Professor JEROME ROBERT

  89. Application of guidelines for aminoglycosides use in French hospitals in 2013–2014

    Article • European Journal of Clinical Microbiology & Infectious Diseases, January 2017, Springer Science + Business Media

    Professor JEROME ROBERT

  90. Group 5 drugs for multidrug-resistant tuberculosis: individual patient data meta-analysis

    Article • European Respiratory Journal, December 2016, European Respiratory Society (ERS)

    Professor JEROME ROBERT

  91. Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors

    Article • European Respiratory Journal, December 2016, European Respiratory Society (ERS)

    Professor JEROME ROBERT

  92. Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis

    Article • European Respiratory Journal, December 2016, European Respiratory Society (ERS)

    Lorenzo Guglielmetti, Professor JEROME ROBERT

  93. Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice

    Article • PLoS Neglected Tropical Diseases, October 2016, PLOS

    Professor JEROME ROBERT

  94. Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe

    Article • American Review of Respiratory Disease, October 2016, American Thoracic Society

    Dr Frank van Leth, Professor JEROME ROBERT, Dr Valeriu Crudu

  95. In vivo Mycobacterium tuberculosisfluoroquinolone resistance emergence: a complex phenomenon poorly detected by current diagnostic tests

    Article • Journal of Antimicrobial Chemotherapy, September 2016, Oxford University Press (OUP)

    Professor JEROME ROBERT

  96. Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method

    Article • European Respiratory Journal, September 2016, European Respiratory Society (ERS)

    Professor JEROME ROBERT

  97. Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis?

    Article • European Respiratory Journal, June 2016, European Respiratory Society (ERS)

    Professor JEROME ROBERT

  98. MYCOBACT-16 - Tolérance et efficacité d’un traitement prolongé avec bédaquiline dans la tuberculose multi résistante

    Article • Médecine et Maladies Infectieuses, June 2016, Elsevier

    Professor JEROME ROBERT

  99. Performance of the New Version (v2.0) of the GenoType MTBDRslTest for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains

    Article • Journal of Clinical Microbiology, April 2016, ASM Journals

    Alexandra Aubry, Professor JEROME ROBERT

  100. Multidrug-resistant bacteria transmitted through high-density EEG in ICU

    Article • Seizure, April 2016, Elsevier

    Benjamin Rohaut, Professor JEROME ROBERT

  101. Propensity Score-Based Approaches to Confounding by Indication in Individual Patient Data Meta-Analysis: Non-Standardized Treatment for Multidrug Resistant Tuberculosis

    Article • PLOS One, March 2016, PLOS

    Professor JEROME ROBERT

  102. Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in community-onset urinary tract infections in France in 2013

    Article • Journal of Infection, February 2016, Elsevier

    Professor JEROME ROBERT

  103. XDR-tuberculosis in France: Community transmission due to non-compliance with isolation precautions

    Article • Médecine et Maladies Infectieuses, February 2016, Elsevier

    Professor JEROME ROBERT

  104. Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis

    Article • Clinical Infectious Diseases, January 2016, Oxford University Press (OUP)

    Professor JEROME ROBERT

  105. qnrA6genetic environment and quinolone resistance conferred onProteus mirabilis

    Article • Journal of Antimicrobial Chemotherapy, January 2016, Oxford University Press (OUP)

    Professor JEROME ROBERT

  106. Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial

    Article • Journal of Antimicrobial Chemotherapy, December 2015, Oxford University Press (OUP)

    Professor JEROME ROBERT

  107. Carbapenem use in French hospitals: A nationwide survey at the patient level

    Article • International Journal of Antimicrobial Agents, December 2015, Elsevier

    Professor JEROME ROBERT

  108. Antibiotic use and good practice in 314 French hospitals: The 2010 SPA2 prevalence study

    Article • Médecine et Maladies Infectieuses, November 2015, Elsevier

    Professor JEROME ROBERT

  109. Corrigendum to ‘Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams’ [Clin Microbiol Infec 21 (2015) 649.e1–649.e10]

    Article • Clinical Microbiology and Infection, November 2015, Elsevier

    Professor JEROME ROBERT

  110. High Rate of Multidrug-Resistant Gram-Negative Bacilli Carriage and Infection in Hospitalized Returning Travelers: a Cross-Sectional Cohort Study

    Article • Journal of Travel Medicine, September 2015, Oxford University Press (OUP)

    Professor JEROME ROBERT

  111. Assessing Primary and Secondary Resistance to Clarithromycin and Amikacin in Infections Due to Mycobacterium avium Complex

    Article • Antimicrobial Agents and Chemotherapy, August 2015, ASM Journals

    Professor JEROME ROBERT

  112. First multicenter study on multidrug resistant bacteria carriage in Chinese ICUs

    Article • BMC Infectious Diseases, August 2015, Springer Science + Business Media

    Professor JEROME ROBERT

  113. Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis

    Article • The International Journal of Tuberculosis and Lung Disease, August 2015, International Union Against Tuberculosis and Lung Disease

    Professor JEROME ROBERT

  114. Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams

    Article • Clinical Microbiology and Infection, July 2015, Elsevier

    Professor JEROME ROBERT

  115. Bédaquiline : de l’in vitro aux essais cliniques d’un nouvel antituberculeux

    Article • Journal des Anti-infectieux, June 2015, Elsevier

    Professor JEROME ROBERT

  116. Detection of OXA-48-like carbapenemase genes by the Xpert® Carba-R test: room for improvement

    Article • International Journal of Antimicrobial Agents, April 2015, Elsevier

    Professor JEROME ROBERT

  117. Impact of the BCG vaccination policy on tuberculous meningitis in children under 6 years in metropolitan France between 2000 and 2011

    Article • Eurosurveillance, March 2015, European Centre for Disease Control and Prevention (ECDC)

    Professor JEROME ROBERT

  118. Survey of French physician practices in treatment and control of transmission of smear-positive tuberculosis

    Article • The International Journal of Tuberculosis and Lung Disease, February 2015, International Union Against Tuberculosis and Lung Disease

    Professor JEROME ROBERT

  119. Registre électronique pour la prise en charge, le suivi et la surveillance des cas de tuberculose à bacilles multi-résistants en France

    Article • Revue des Maladies Respiratoires, January 2015, Elsevier

    Professor JEROME ROBERT

  120. « Groupe thérapeutique des infections à mycobactéries difficiles à traiter » et prise en charge des TB MDR : bilan 2005–2013

    Article • Revue des Maladies Respiratoires, January 2015, Elsevier

    Professor JEROME ROBERT

  121. Molecular Diagnosis of Fluoroquinolone Resistance in Mycobacterium tuberculosis

    Article • Antimicrobial Agents and Chemotherapy, December 2014, ASM Journals

    Professor JEROME ROBERT, Alexandra Aubry

  122. Molecular epidemiology of OXA-48-producing Klebsiella pneumoniae in France

    Article • Clinical Microbiology and Infection, December 2014, Elsevier

    Professor JEROME ROBERT

  123. Compassionate Use of Bedaquiline for the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Interim Analysis of a French Cohort

    Article • Clinical Infectious Diseases, October 2014, Oxford University Press (OUP)

    Professor JEROME ROBERT

  124. Significant Difference in Drug Susceptibility Distribution between Mycobacterium avium and Mycobacterium intracellulare

    Article • Journal of Clinical Microbiology, October 2014, ASM Journals

    Professor JEROME ROBERT

  125. Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis

    Article • Clinical Infectious Diseases, August 2014, Oxford University Press (OUP)

    Professor JEROME ROBERT

  126. Incidence rates of carbapenemase-producing Enterobacteriaceae clinical isolates in France: a prospective nationwide study in 2011-12

    Article • Journal of Antimicrobial Chemotherapy, June 2014, Oxford University Press (OUP)

    Professor JEROME ROBERT

  127. K-06: Évaluation de nouveaux traitements oraux intermittents dans un modèle murin d’infection à Mycobacterium ulcerans

    Article • Médecine et Maladies Infectieuses, June 2014, Elsevier

    Professor JEROME ROBERT

  128. Chirurgie et tuberculose multi/ultrarésistante : une revue de la littérature réhabilite une intervention adjuvante à l’antibiothérapie chez des patients sélectionnés

    Article • Revue des Maladies Respiratoires, June 2014, Elsevier

    Professor JEROME ROBERT

  129. Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France, 2004 to 2012

    Article • Eurosurveillance, May 2014, European Centre for Disease Control and Prevention (ECDC)

    Professor JEROME ROBERT

  130. Pseudomonas aeruginosa in French hospitals between 2001 and 2011: back to susceptibility

    Article • European Journal of Clinical Microbiology & Infectious Diseases, May 2014, Springer Science + Business Media

    Professor JEROME ROBERT

  131. First report of the predominance of clonal complex 398 Staphylococcus aureus strains in osteomyelitis complicating diabetic foot ulcers: a national French study

    Article • Clinical Microbiology and Infection, April 2014, Elsevier

    Professor JEROME ROBERT

  132. Rifampicin mono-resistant tuberculosis in France: a 2005–2010 retrospective cohort analysis

    Article • BMC Infectious Diseases, January 2014, Springer Science + Business Media

    Professor JEROME ROBERT

  133. Decrease in the incidence of culture-positive meningitis and cerebral tuberculomas in France from 1990 to 2007

    Article • Epidemiology and Infection, September 2013, Cambridge University Press

    Professor JEROME ROBERT

  134. Different Factors Associated with CTX-M-Producing ST131 and Non-ST131 Escherichia coli Clinical Isolates

    Article • PLOS One, September 2013, PLOS

    Dr Sylvain Brisse, Professor JEROME ROBERT

  135. A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union

    Article • Eurosurveillance, August 2013, European Centre for Disease Control and Prevention (ECDC)

    Professor JEROME ROBERT

  136. Assessment of Organizational Measures to Prevent Nosocomial Tuberculosis in Health Facilities of 4 Sub-Saharan Countries in 2010

    Article • Infection Control and Hospital Epidemiology, February 2013, Cambridge University Press

    Professor JEROME ROBERT

  137. Aerosolized Antibiotics for Ventilator-associated Pneumonia

    Article • Anesthesiology, December 2012, Wolters Kluwer Health

    Professor JEROME ROBERT

  138. Efficacy of High-dose Nebulized Colistin in Ventilator-associated Pneumonia Caused by Multidrug-resistant Pseudomonas aeruginosa  and Acinetobacter baumannii 

    Article • Anesthesiology, December 2012, Wolters Kluwer Health

    Professor JEROME ROBERT

  139. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

    Article • European Respiratory Journal, October 2012, European Respiratory Society (ERS)

    Dr Dennis Falzon, Professor JEROME ROBERT

  140. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis

    Article • European Respiratory Journal, October 2012, European Respiratory Society (ERS)

    Professor JEROME ROBERT

  141. Alliance contre les bactéries multirésistantes : sauvons les antibiotiques !

    Article • Annales Françaises d Anesthésie et de Réanimation, September 2012, Elsevier

    Professor JEROME ROBERT

  142. Link Between Carbapenemase‐ProducingEnterobacteriaCarriage and Cross‐Border Exchanges: Eight‐Year Surveillance in a Large French Multihospitals Institution

    Article • Journal of Travel Medicine, September 2012, Oxford University Press (OUP)

    Professor JEROME ROBERT

  143. Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients

    Article • PLoS Medicine, August 2012, PLOS

    Professor JEROME ROBERT

  144. Increase in primary drug resistance of Mycobacterium tuberculosis in younger birth cohorts in France

    Article • Journal of Infection, June 2012, Elsevier

    Professor JEROME ROBERT

  145. Impact of a 14-year screening programme on tuberculosis transmission among the homeless in Paris

    Article • The International Journal of Tuberculosis and Lung Disease, May 2012, International Union Against Tuberculosis and Lung Disease

    Professor JEROME ROBERT

  146. Distinguishing Colonization From Infection With Staphylococcus aureus in Diabetic Foot Ulcers With Miniaturized Oligonucleotide Arrays: A French multicenter study

    Article • Diabetes Care, February 2012, American Diabetes Association

    Professor JEROME ROBERT

  147. Patient's Origin and Lifestyle Associated with CTX-M-Producing Escherichia coli: A Case-Control-Control Study

    Article • PLOS One, January 2012, PLOS

    Professor JEROME ROBERT

  148. Point prevalence survey of antibiotic use in French hospitals in 2009

    Article • Journal of Antimicrobial Chemotherapy, January 2012, Oxford University Press (OUP)

    Professor JEROME ROBERT

  149. Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE)

    Article • Antimicrobial Resistance and Infection Control, January 2012, Springer Science + Business Media

    Professor JEROME ROBERT

  150. Multidrug‐ResistantAcinetobacter baumanniiInfections in Three Returning Travelers Evacuated From Algeria, Thailand, and Turkey After Hospitalization in Local Intensive Care Units

    Article • Journal of Travel Medicine, September 2011, Oxford University Press (OUP)

    Professor JEROME ROBERT

  151. Nebulized Ceftazidime and Amikacin in Ventilator-associated Pneumonia Caused byPseudomonas aeruginosa

    Article • American Review of Respiratory Disease, July 2011, American Thoracic Society

    Professor JEROME ROBERT

  152. Halte à la résistance : sauvons les antibiotiques

    Article • Médecine et Maladies Infectieuses, July 2011, Elsevier

    Professor JEROME ROBERT

  153. Low carriage of vancomycin-resistant enterococci in the digestive tract of French hospitalised patients: a nationwide prospective study in 2006

    Article • Journal of Hospital Infection, February 2011, Elsevier

    Professor JEROME ROBERT

  154. Comparison of Nine Phenotypic Methods for Detection of Extended-Spectrum  -Lactamase Production by Enterobacteriaceae

    Article • Journal of Clinical Microbiology, January 2011, ASM Journals

    Professor JEROME ROBERT

  155. Panton-Valentine Leukocidin-Positive and Toxic Shock Syndrome Toxin 1-Positive Methicillin-ResistantStaphylococcus aureus: a French Multicenter Prospective Study in 2008

    Article • Antimicrobial Agents and Chemotherapy, January 2011, ASM Journals

    Professor JEROME ROBERT

  156. Résistance aux antituberculeux et impasse thérapeutique

    Article • médecine/sciences, November 2010, EDP Sciences

    Professor JEROME ROBERT

  157. Nationwide Investigation of Extended-Spectrum β-Lactamases, Metallo-β-Lactamases, and Extended-Spectrum Oxacillinases Produced by Ceftazidime-Resistant Pseudomonas aeruginosa Strains in France

    Article • Antimicrobial Agents and Chemotherapy, June 2010, ASM Journals

    Dr Pierre Mariotte, Professor JEROME ROBERT

  158. Curbing Methicillin-Resistant Staphylococcus aureus in 38 French Hospitals Through a 15-Year Institutional Control Program

    Article • Archives of Internal Medicine, March 2010, American Medical Association (AMA)

    Professor JEROME ROBERT

  159. Effect of Catheter-Lock Solutions on Catheter-Related Infection and Inflammatory Syndrome in Hemodialysis Patients: Heparin versus Citrate 46% versus Heparin/Gentamicin

    Article • Blood Purification, January 2010, Karger Publishers

    Professor JEROME ROBERT

  160. Rapid Curbing of a Vancomycin-ResistantEnterococcus faeciumOutbreak in a Nephrology Department

    Article • Clinical Journal of the American Society of Nephrology, August 2009, American Society of Nephrology

    Professor JEROME ROBERT

  161. Carriage of Methicillin-Resistant Staphylococcus aureus in Home Care Settings

    Article • Archives of Internal Medicine, August 2009, American Medical Association (AMA)

    Professor JEROME ROBERT

  162. Impacts of Dosing Frequency of the Combination Rifampin-Streptomycin on Its Bactericidal and Sterilizing Activities against Mycobacterium ulcerans in Mice

    Article • Antimicrobial Agents and Chemotherapy, April 2009, ASM Journals

    Professor JEROME ROBERT

  163. Nationwide survey of extended-spectrum β-lactamase-producing Enterobacteriaceae in the French community setting

    Article • Journal of Antimicrobial Chemotherapy, March 2009, Oxford University Press (OUP)

    Professor JEROME ROBERT

  164. Systematic Microbiological Tests in Kidney Transplantation and Their Value in Predicting Posttransplantation Infection

    Article • Transplantation Proceedings, March 2009, Elsevier

    Professor JEROME ROBERT

  165. Increase in hospital-acquired bloodstream infections caused by extended spectrum β-lactamase-producing Escherichia coli in a large French teaching hospital

    Article • European Journal of Clinical Microbiology & Infectious Diseases, November 2008, Springer Science + Business Media

    Professor JEROME ROBERT

  166. La résistance aux antituberculeux en France à travers les données des réseaux Azay-Mycobactéries et du Centre National de Référence des Mycobactéries

    Article • Médecine et Maladies Infectieuses, June 2008, Elsevier

    Professor JEROME ROBERT

  167. Entérocoques résistants à la vancomycine : données des réseaux de l’ONERBA et résultats de l’enquête nationale trans-réseaux 2006 sur le portage digestif

    Article • Médecine et Maladies Infectieuses, June 2008, Elsevier

    Professor JEROME ROBERT

  168. Bactericidal and Sterilizing Activities of Several Orally Administered Combined Regimens against Mycobacterium ulcerans in Mice

    Article • Antimicrobial Agents and Chemotherapy, April 2008, ASM Journals

    Professor JEROME ROBERT

  169. Extended-spectrum β-lactamases in long-term-care facilities

    Article • Clinical Microbiology and Infection, January 2008, Elsevier

    Professor JEROME ROBERT

  170. Evaluation of data quality in a laboratory-based surveillance of M. tuberculosis drug resistance and impact on the prevalence of resistance: France, 2004

    Article • Epidemiology and Infection, November 2007, Cambridge University Press

    Professor JEROME ROBERT

  171. A 10-year prospective surveillance of Mycobacterium tuberculosis drug resistance in France 1995 2004

    Article • European Respiratory Journal, November 2007, European Respiratory Society (ERS)

    Professor JEROME ROBERT

  172. Orally Administered Combined Regimens for Treatment of Mycobacterium ulcerans Infection in Mice

    Article • Antimicrobial Agents and Chemotherapy, July 2007, ASM Journals

    Professor JEROME ROBERT

  173. Preemptive Isolation to Prevent Methicillin-Resistant Staphylococcus aureus Cross-Transmission in Diabetic Foot

    Article • Diabetes Care, June 2007, American Diabetes Association

    Professor JEROME ROBERT

  174. Conduite à tenir devant un malade porteur d'un entérocoque résistant à la vancomycine

    Article • Réanimation, June 2007, Elsevier

    Professor JEROME ROBERT

  175. An intervention programme for the management of multidrug-resistant tuberculosis in France

    Article • International Journal of Antimicrobial Agents, April 2007, Elsevier

    Professor JEROME ROBERT

  176. Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene

    Article • International Journal of Antimicrobial Agents, April 2007, Elsevier

    Professor JEROME ROBERT

  177. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients*

    Article • Critical Care Medicine, April 2007, Wolters Kluwer Health

    Professor JEROME ROBERT

  178. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis

    Article • The Lancet, December 2006, Elsevier

    Professor JEROME ROBERT

  179. Activité de l’ertapénème et d’autres antibiotiques sur les bacilles aérobies à Gram négatif isolés d’infections respiratoires et abdominales d’origine communautaire en France 2003

    Article • Antibiotiques, December 2006, Elsevier

    Professor JEROME ROBERT

  180. An evaluation of data quality in a network for surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs in Ile-de-France region-2001–2002

    Article • European Journal of Epidemiology, November 2006, Springer Science + Business Media

    Professor JEROME ROBERT

  181. Curing Mycobacterium ulcerans Infection in Mice with a Combination of Rifampin-Streptomycin or Rifampin-Amikacin

    Article • Antimicrobial Agents and Chemotherapy, November 2006, ASM Journals

    Professor JEROME ROBERT

  182. Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002–2005

    Article • Clinical Microbiology and Infection, October 2006, Elsevier

    Professor JEROME ROBERT

  183. Gentamicin-Susceptible or Gentamicin-Resistant Methicillin-ResistantStaphylococcus aureusA Case-Case Study

    Article • Infection Control and Hospital Epidemiology, August 2006, Cambridge University Press

    Professor JEROME ROBERT

  184. In Vitro and In Vivo Activities of Rifampin, Streptomycin, Amikacin, Moxifloxacin, R207910, Linezolid, and PA-824 against Mycobacterium ulcerans

    Article • Antimicrobial Agents and Chemotherapy, June 2006, ASM Journals

    Professor JEROME ROBERT

  185. Implementation of isolation precautions: role of a targeted information flyer

    Article • Journal of Hospital Infection, February 2006, Elsevier

    Professor JEROME ROBERT

  186. Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983–2002

    Article • Journal of Antimicrobial Chemotherapy, January 2006, Oxford University Press (OUP)

    Professor JEROME ROBERT

  187. Modification des caractéristiques épidémiologiques de la tuberculose multirésistante en France en 2002-2003

    Article • Revue des Maladies Respiratoires, January 2006, Elsevier

    Professor JEROME ROBERT

  188. Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease

    Article • European Respiratory Journal, December 2005, European Respiratory Society (ERS)

    Dr Jean-Louis Herrmann, Professor JEROME ROBERT

  189. Three-year survey of community-acquired methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a French university hospital

    Article • Journal of Hospital Infection, December 2005, Elsevier

    Professor JEROME ROBERT

  190. Résistance aux antituberculeux

    Article • Archives de Pédiatrie, August 2005, Elsevier

    Professor JEROME ROBERT

  191. Methicillin-resistant Staphylococcus aureus producing Panton–Valentine leukocidin in a retrospective case series from 12 French hospital laboratories, 2000–2003

    Article • Clinical Microbiology and Infection, July 2005, Elsevier

    Professor JEROME ROBERT

  192. Résistance aux antibiotiques : des Chiffres de l'ONERBA au Bon Usage

    Article • Médecine et Maladies Infectieuses, June 2005, Elsevier

    Professor JEROME ROBERT

  193. Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains

    Article • Journal of Medical Microbiology, February 2005, Society for General Microbiology

    Professor JEROME ROBERT

  194. Nosocomial infections and hospital mortality: a multicentre epidemiological study

    Article • Journal of Hospital Infection, December 2004, Elsevier

    Professor JEROME ROBERT

  195. A-04 Incidence et caractéristiques de la méningite tuberculeuse en France en 2000

    Article • Médecine et Maladies Infectieuses, June 2004, Elsevier

    Professor JEROME ROBERT

  196. Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact

    Article • Diabetic Medicine, April 2004, Wiley

    Professor JEROME ROBERT

  197. Preventing Central Venous Catheter-Associated Primary Bloodstream Infections: Characteristics of Practices Among Hospitals Participating in the Evaluation of Processes and Indicators in Infection Control (EPIC) Study

    Article • Infection Control and Hospital Epidemiology, December 2003, Cambridge University Press

    Professor JEROME ROBERT

  198. Multidrug-resistant tuberculosis: eight years of surveillance in France

    Article • European Respiratory Journal, November 2003, European Respiratory Society (ERS)

    Professor JEROME ROBERT

  199. Comparison of US and non-US central venous catheter infection rates: Evaluation of processes and indicators in infection control study

    Article • American Journal of Infection Control, June 2003, Elsevier

    Professor JEROME ROBERT

  200. La multirésistance (MDR) de Mycobacterium tuberculosis aux antibiotiques en France depuis 1992

    Article • Médecine et Maladies Infectieuses, March 2003, Elsevier

    Professor JEROME ROBERT

  201. Bactericidal Activity of Rifampin-Amikacin against Mycobacterium ulcerans in Mice

    Article • Antimicrobial Agents and Chemotherapy, October 2002, ASM Journals

    Professor JEROME ROBERT

  202. Sixty-three Cases of Mycobacterium marinum Infection

    Article • Archives of Internal Medicine, August 2002, American Medical Association (AMA)

    Professor JEROME ROBERT

  203. Recommandations des experts de la Société de réanimation de langue française, janvier 2002Prévention de la transmission croisée en réanimation

    Article • Réanimation, June 2002, Elsevier

    Professor JEROME ROBERT

  204. Isolement respiratoire chez l’adulte de réanimation

    Article • Réanimation, June 2002, Elsevier

    Professor JEROME ROBERT

  205. Lung Tissue Concentrations of Nebulized Amikacin during Mechanical Ventilation in Piglets with Healthy Lungs

    Article • American Review of Respiratory Disease, January 2002, American Thoracic Society

    Professor JEROME ROBERT

  206. Évolution de la sensibilité aux quinolones et aux fluoroquinolones des bacilles à Gram négatif aérobies isolés dans un hôpital universitaire (1992–2000)

    Article • Pathologie Biologie, January 2002, Elsevier

    Professor JEROME ROBERT

  207. Activities of New Macrolides and Fluoroquinolones against Mycobacterium ulcerans Infection in Mice

    Article • Antimicrobial Agents and Chemotherapy, November 2001, ASM Journals

    Professor JEROME ROBERT

  208. Efficacies of Clarithromycin Regimens against Mycobacterium xenopi in Mice

    Article • Antimicrobial Agents and Chemotherapy, November 2001, ASM Journals

    Professor JEROME ROBERT

  209. Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98

    Article • Clinical Microbiology and Infection, October 2001, Elsevier

    Professor JEROME ROBERT

  210. Outcomes of Primary and Catheter-related Bacteremia

    Article • American Review of Respiratory Disease, June 2001, American Thoracic Society

    Professor JEROME ROBERT

  211. Global Trends in Resistance to Antituberculosis Drugs

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2001, New England Journal of Medicine (NEJM/MMS)

    Christopher Dye, Professor JEROME ROBERT

  212. Impact of Hospital Care on Incidence of Bloodstream Infection: The Evaluation of Processes and Indicators in Infection Control Study

    Article • April 2001, Centers for Disease Control and Prevention (CDC)

    Professor JEROME ROBERT

  213. Activities of Several Antimicrobials againstMycobacterium ulcerans Infection in Mice

    Article • Antimicrobial Agents and Chemotherapy, September 2000, ASM Journals

    Professor JEROME ROBERT

  214. The Influence of the Composition of the Nursing Staff on Primary Bloodstream Infection Rates in a Surgical Intensive Care Unit

    Article • Infection Control and Hospital Epidemiology, January 2000, Cambridge University Press

    Professor JEROME ROBERT

  215. Outcome of Multi-drug-resistant Tuberculosis in France

    Article • American Review of Respiratory Disease, August 1999, American Thoracic Society

    Professor JEROME ROBERT

  216. Type II Topoisomerase Mutations in Ciprofloxacin-Resistant Strains of Pseudomonas aeruginosa

    Article • Antimicrobial Agents and Chemotherapy, January 1999, ASM Journals

    Professor JEROME ROBERT

  217. Pacemaker Endocarditis Due to Candida albicans: Case Report and Review

    Article • Clinical Infectious Diseases, December 1997, Oxford University Press (OUP)

    Professor JEROME ROBERT

  218. Pharmacodynamics of antibiotics in fibrin clots

    Article • Journal of Antimicrobial Chemotherapy, January 1993, Oxford University Press (OUP)

    Professor JEROME ROBERT

  219. Reexpansion Pulmonary Edema Localized to a Lobe

    Article • CHEST Journal, May 1989, Elsevier

    Professor JEROME ROBERT

  220. Article • PLOS

    Professor JEROME ROBERT